Advancing Solid Tumor Immunotherapy: Primmune Therapeutics Raises $8.6M

Read about Primmune Therapeutics' Series B extension and their plans to revolutionize solid tumor immunotherapy with a novel ...
ALZFORUM

CpG 1018®

CpG 1018 is a proprietary immune adjuvant made up of short, unmethylated cytosine-phosphate-guanine oligodeoxynucleotides (CpG ODNs). Its components mimic bacterial DNA to activate innate immunity ...